[Selected parameters of coagulation, fibrinolysis and antibodies to fibrinogen in lung cancer].
Levels of fibrinogen, fibrinogen degradation products, clot lysis time, thrombin time, titer of antifibrinogen antibodies were studied in 40 lung cancer patients and 30 honorary blood donors. Increase of fibrinolytic activity was observed which was related to clinical stage but not to type of cancer. Statistically significant increase in fibrinogen levels (p < 0.01) fibrinogen degradation products levels, antifibrinogen antibodies, prolonged thrombin time and clot lysis time was found in all lung cancer patients.
Kondera-Anasz
Z
Z
Katedry i Zakładu Immunologii i Serologii Sl.AM, Katowicach.
Gisman
K
K
Mertas
A
A
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D001777:Blood Coagulation / Q000502:physiology*; D002277:Carcinoma / Q000473:pathology / Q000503:physiopathology; D005342:Fibrinolysis / Q000276:immunology / Q000502:physiology*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging
D000906:Antibodies
Wybrane parametry krzepniecia i fibrynolizy oraz przeciwciała przeciwfibrynogenowe w raku płuca.